General Information of the Compound
Compound ID
CP0919047
Compound Name
4-phenyl-3,4,5,6-tetrahydrobenzo[h]quinazoline-2(1H)-thione
    Show/Hide
Structure
Formula
C18H16N2S
Molecular Weight
292.407
Canonical SMILES
S=C1NC2=C(CCc3ccccc32)C(c2ccccc2)N1
    Show/Hide
InChI
InChI=1S/C18H16N2S/c21-18-19-16(13-7-2-1-3-8-13)15-11-10-12-6-4-5-9-14(12)17(15)20-18/h1-9,16H,10-11H2,(H2,19,20,21)
    Show/Hide
InChIKey
FDBVJMGYNUBQKV-UHFFFAOYSA-N
Physicochemical Property
logP
3.5629
Rotatable Bonds
1
Heavy Atom Count
21
Polar Areas
24.06
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
1
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 2738054
SID: 96078813
ChEMBL ID
CHEMBL1939988
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02149, Transient receptor potential cation channel subfamily A member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS